Abnormal expression of p62 has been linked to the onset and advancement of several cancers, including lung, endometrial (Zhu et al. 2018, Tang et al. 2021), neck and head squamous cell carcinoma (Noman et al. 2020, Wang et al. 2020), and prostate cancer (Jiang et al. 2020). Here, SQSTM1 is linked to cancer.